At A Glance
1
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees783
Fundamentals
How The Business Makes Money
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Industry Medical - Care Facilities
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIKUNKNOWN_VTIAF
ISINDE000A0BL849
Phone49 341 48792 40
AddressDeutscher Platz 5a, Leipzig, 04103, DE
SEC EDGAR